Question Bank › Earned recurrence: demand arriving from first-ha

Earned recurrence: demand arriving from first-hand-proven buyers, still early

Calls Tested
489
Answered YES
4
Hit Rate
0.8%
rare by design

scPharmaceuticals Inc. (SCPH) — this company's answers

NO on the Q3 2023 call 2023-11-08 B
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes that a meaningful share of current business growth is arriving without the company having to persuade the buyer—i.e., demand generated by parties with direct prior experience (customers returning, expanding, etc.)—and that this pattern is still early with most contribution ahead. We need to analyze the transcript. The company is scPharmaceuticals, launching FUROSCIX. They report Q3 2023 results. Key points: They have a sales force, they added territories, they have in-services, they have payer agreements. The question is about "earned recurrence" where prior experience drives demand. Does management describe that existing users (prescribers, patients) are generating business on their own initiative, and that this is still early? Look for statements about repeat prescriptions, prescribers writing more, patients coming back, etc. Steve Parsons mentions: "We've had 1,119 unique prescribers, almost doubling from 631 through June 30th." That's new prescribers, not necessarily repeat. They talk about in-services to train offices. They talk about fill rates. They mention that doctors are writing more consistently. John Tucker: "we've really seen a lot of the physicians now starting to write more consistently. October was a really strong month for us and November is off to a really good start." That suggests repeat prescribing from existing physicians. Also, they mention that patients are being prescribed FUROSCIX and then coming back? They talk about "preventative pre-admission" and "post discharge" usage. They mention that doctors are ordering product in advance and having it ready for when patients need it. That suggests that once a patient has used it, they might get it again? But the question is about "parties with first-hand experience of the company's offering are generating business on their own initiative" - i.e., existing customers (prescribers, patients) are coming back without persuasion. The transcript mentions that physicians are writing more consistently, and that they are selecting patients who have better access. But is that "earned recurrence" or just the company's sales force becoming more effective? The company is still actively selling, adding territories, doing in-services. The growth is attributed to their sales force and payer agreements.

← Back to the full SCPH analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that a MEANINGFUL SHARE OF THE COMPANY'S CURRENT BUSINESS GROWTH is arriving WITHOUT THE COMPANY HAVING TO PERSUADE THE BUYER — that is, demand is increasingly generated by parties with DIRECT PRIOR EXPERIENCE of what the company provides (customers with first-hand experience expanding, returning, renewing, deepening, or referencing; parties that have already used, deployed, trialed, tested, sampled, piloted, or bought an initial piece of what the company sells now coming back for more; an installed base pulling follow-on business through on its own), rather than by the company's own selling, marketing, pricing, promotions, or new-logo acquisition push — AND does management convey that this earned-recurrence pattern is STILL EARLY enough that most of the business it will generate is still ahead of the reported results? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent phenomenon: parties with first-hand experience of the company's offering are generating business on their own initiative — as a real, current, observable pattern in how the company's demand is being produced today — and management treats this as meaningful to where the company is heading with most of the contribution still ahead. Management need not use any particular vocabulary; it may show up in how it describes demand sources, customer behavior, reorder dynamics, expansion of proven relationships, or the decreasing role of persuasion in winning business. Answer NO if growth is described mainly through the company's own selling push, pricing actions, promotions, marketing, or new-logo acquisition, however strong. NO if the 'return' activity is merely a contractually forced renewal, a standing subscription auto-charge, or an ordinary slow-order cadence, with no sense that prior experience itself is now driving the demand. NO if the earned recurrence is only hoped for, planned, or projected rather than already observable. NO if the only evidence is one isolated anecdote with no broader pattern. NO if the recurrence is already mature and fully reflected in the reported results, with no meaningful contribution still ahead. NO if management attributes the shift to a one-time event, a temporary spike, or a pull-forward it expects to reverse. NO if the idea appears only in an analyst's question that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+

How the model reasoned

ATI · Q1 2018 → YESThe question is about whether management describes a meaningful share of the company's current business growth arriving without the company having to persuade the buyer, from parties with direct prior...YES Management describes a meaningful share of current growth coming from parties with direct prior experience—Boeing and Airbus exercising their supply chain after assessing geopolitical risks, plus customers awarding forgings based on 2017 actions and continuing to do so in 2018—while treating this as still early, with most of the contribution 2019–2020 and beyond as the multi-year production expansion unfolds.
LTRX · Q3 2024 → YESThe question is: Does management describe that a MEANINGFUL SHARE OF THE COMPANY'S CURRENT BUSINESS GROWTH is arriving WITHOUT THE COMPANY HAVING TO PERSUADE THE BUYER — demand generated by parties wi...
DASH · Q3 2023 → YESThe question is: Does management describe that a MEANINGFUL SHARE OF THE COMPANY'S CURRENT BUSINESS GROWTH is arriving WITHOUT THE COMPANY HAVING TO PERSUADE THE BUYER — demand generated by parties wi...

More from the question bank

Borrowed urgency: counterparties are racing Living hand-to-mouth on their own outputStory upgraded mid-callConversation has moved to deliveryDeprived of a working part of itselfBought the ticket, hasn't taken the rideAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.